Syneos Health Podcast | Patient Assistance: The Best Deal in Pharma
Patient assistance programs can make a huge difference for patients who need expensive medicines but can't afford them.
In this episode, Jeff Stewart talks with Dave MacLeod, Managing Director, Value & Access at Syneos Health about the benefits and challenges of patient assistance programs, which provide free or low-cost medicines to eligible patients. They discuss how these programs can improve access, adherence, and outcomes, as well as the operational and regulatory issues involved in running them. Covering key topics such as the Inflation Reduction Act (IRA), the impact of technology and AI in patient services, and the challenges posed by copay accumulators and maximizers, Dave sheds light on the complexities of navigating copay assistance optimization and the strategies employed to mitigate the effects on patients and manufacturers alike.
For more from our Value & Access experts, check out these topics:
Syneos Health Podcast | Real Talk About the Inflation Reduction Act
BLOG: Industry Cheers “Co-Pay Accumulator” Ruling, Should Prep for What’s Next
Potential Impact of European Pharma Legislation on Commercialization and Access of New Therapies
BLOG: What Can We Learn From ICER's New Value Framework
Syneos Health Podcast | Market Access for Weight Loss Drugs
MM+M Podcast | Gaining Access and Delivering Pull-Through in IDNs and Key Accounts
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Related
Looking for exclusive insight?
